Loading…
Charming Medical Limited is projected to rise to $40.68 by 2027, a +39% move from its current price of $29.36. MCTA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $28.93 | $29.36 | $29.81 | +0.03% |
| Jul 13 | $28.75 | $29.37 | $30.00 | +0.05% |
| Jul 14 | $28.63 | $29.38 | $30.15 | +0.08% |
| Jul 15 | $28.52 | $29.38 | $30.28 | +0.10% |
| Jul 16 | $28.42 | $29.39 | $30.39 | +0.13% |
| Jul 17 | $28.34 | $29.40 | $30.50 | +0.15% |
| Jul 18 | $28.27 | $29.41 | $30.59 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $28.27 | $29.41 | $30.59 | +0.18% |
| Week 2 | $27.85 | $29.46 | $31.16 | +0.35% |
| Week 3 | $27.55 | $29.51 | $31.61 | +0.53% |
| Week 4 | $27.31 | $29.56 | $32.00 | +0.71% |
| Week 5 | $27.11 | $29.62 | $32.36 | +0.89% |
| Week 6 | $26.92 | $29.67 | $32.69 | +1.06% |
| Week 7 | $26.76 | $29.72 | $33.00 | +1.24% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Charming Medical Limited operates in the Healthcare space, providing beauty, wellness, and postpartum services under the Beauty Lab brand name in Hong Kong. The company was founded in 2016 and is headquartered in Causeway Bay, Hong Kong. Its services include womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, traditional Chinese medicine (TCM)-inspired prenatal massage, and Indonesian traditional abdominal binding.
The business also offers TCM-inspired supplements, including Beauty Lab home herbal uterine care patch, probiotic intimate wash, and Yin nourishing pill sets, as well as beauty products such as ginseng soothing anti-allergy moisturizing wash for skin issues and scalp health. In addition, Charming Medical provides consultancy services to train other beauty salons and wellness centers in TCM-inspired therapy techniques and dietary therapy. The company’s products are used for a range of women’s health issues, and it operates wellness centres.
Charming Medical Limited (MCTA) is currently priced at $29.36 with a market capitalization of $504.26M, and it ranks 2854 by market capitalization. The current price and market position frame a stock that sits near the 2026 forecast horizon, where the model shows a near-flat base around the current level. The 2026 forecast lists a min of $29.35, an avg of $29.36, and a max of $40.03 with an ROI of 0 and a NEUTRAL sentiment.
Beginning in 2027, the forecast turns bullish, with rising averages and higher upside potential through 2035 and beyond: 2027 avg $41.64, 2028 avg $52.96, 2029 avg $68.74, 2030 avg $84.39, 2031 avg $89.72, 2032 avg $103.16, 2033 avg $120.99, 2034 avg $139.41, 2035 avg $174.13, 2040 avg $272.54, and 2050 avg $678.73. Corresponding ROIs expand to 41.8% in 2027, 80.4% in 2028, 134.2% in 2029, 187.5% in 2030, 205.6% in 2031, 251.4% in 2032, 312.1% in 2033, 374.9% in 2034, 493.2% in 2035, 828.4% in 2040, and 2212.1% by 2050, with a bullish sentiment across these years. These figures are estimates and not guarantees of future results.
A major floor 0.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major level 0.0% below — it may now act as a floor.
Key MCTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MCTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $29.35 | Buy | $29.35 | Buy |
| MA 10 | $29.35 | Buy | $29.35 | Buy |
| MA 20 | $29.35 | Buy | $29.35 | Buy |
| MA 50 | $29.35 | Buy | $29.33 | Buy |
| MA 100 | $29.35 | Buy | $28.63 | Buy |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 78.51 | Sell |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -66.67 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.00 | Buy |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 50.00 | Neutral |
| Momentum (10) | 0.00 | Neutral |
| Aroon Osc (25) | 0.00 | Neutral |
| Hull MA (9) | 29.35 | Buy |
| ADX (14) | 57.02 | Buy |
| ATR (14) | 0.00 | Info |
The 30-day technical picture is neutral, with RSI14 at 80 and the 50-day simple moving average (SMA50) at $29.35. The 30-day range runs from a low of $26.41 to a high of $32.62. Both the documented support and resistance are at $29.35, and the annualized volatility is 30%.
These signals suggest a tight near-term tape with potential for upside if momentum persists, though the RSI reading near 80 indicates overbought conditions that could precede a pullback or a pause in upside moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $29.35 | $29.36 | $39.56 | 0% | Neutral | |
| $32.28 | $40.68 | $54.30 | +39% | Bullish | |
| $40.31 | $52.30 | $72.52 | +78% | Bullish | |
| $50.94 | $67.69 | $96.70 | +131% | Bullish | |
| $61.10 | $82.95 | $121.49 | +183% | Bullish | |
| $65.63 | $90.83 | $135.98 | +209% | Bullish | |
| $72.53 | $102.21 | $156.03 | +248% | Bullish | |
| $82.12 | $117.70 | $182.89 | +301% | Bullish | |
| $96.01 | $139.85 | $220.87 | +376% | Bullish | |
| $116.23 | $171.93 | $275.68 | +486% | Bullish | |
| $172.66 | $273.98 | $467.98 | +833% | Bullish | |
| $377.77 | $676.75 | $1,267.33 | +22.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $29.35 | $29.36 | $35.56 | +0.00% |
| August 2026 | $25.08 | $29.63 | $35.98 | +0.94% |
| September 2026 | $25.24 | $30.04 | $36.89 | +1.38% |
| October 2026 | $26.18 | $31.36 | $38.88 | +4.39% |
| November 2026 | $26.38 | $31.76 | $39.70 | +1.29% |
| December 2026 | $25.97 | $31.42 | $39.56 | -1.08% |
Click any year to see its month-by-month MCTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Charming Medical Limited's 2026 outlook centres on $29.36, within a $29.35 to $39.56 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, MCTA could reach as high as $54.30, with a base case around $40.68 and support toward $32.28 — roughly +39% from $29.36. Buyers look set to stay in control over this stretch.
Expect MCTA to range from $40.31 to $72.52 through 2028. The $52.30 average target implies a +78% move from current prices. That is up +29% on the projected 2027 average. Momentum favours further upside here.
The MCTA price prediction for 2029 points to an average of $67.69 (low $50.94, high $96.70) — a potential gain of +131% on today's $29.36. Buyers look set to stay in control over this stretch.
In 2030, MCTA is projected to trade between $61.10 and $121.49, averaging $82.95 — a potential gain of +183% from today's $29.36. That is up +23% on the projected 2029 average. Momentum favours further upside here.
Charming Medical Limited's 2031 outlook centres on $90.83, within a $65.63 to $135.98 range. That is up +10% on the projected 2030 average. That marks a +209% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, MCTA could reach as high as $156.03, with a base case around $102.21 and support toward $72.53 — roughly +248% from $29.36. Momentum favours further upside here.
Expect MCTA to range from $82.12 to $182.89 through 2033. The $117.70 average target implies a +301% move from current prices. That is up +15% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The MCTA price prediction for 2034 points to an average of $139.85 (low $96.01, high $220.87) — a potential gain of +376% on today's $29.36. Momentum favours further upside here.
In 2035, MCTA is projected to trade between $116.23 and $275.68, averaging $171.93 — a potential gain of +486% from today's $29.36. That is up +23% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Charming Medical Limited's 2040 outlook centres on $273.98, within a $172.66 to $467.98 range. That is up +59% on the projected 2035 average. That marks a +833% change versus current levels. Momentum favours further upside here.
By 2050, MCTA could reach as high as $1,267.33, with a base case around $676.75 and support toward $377.77 — roughly +22.1x from $29.36. Buyers look set to stay in control over this stretch.
Investing $1,000 in MCTA today (≈ 34.065747 MCTA) could be worth
$23,054.14
+$22,054.14 (+2205%) by 2050 · US Dollar
Based on the average projected MCTA price of $676.75 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MCTAwould be worth at today's price.
$1,000 invested in MCTA on Oct 21, 2025 (≈ 142.857143 MCTA) would be worth
$4,193.57
+$3,193.57 (+319.4%) today · 4.19× · US Dollar
Based on a MCTA entry price of $7 vs. today's $29.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $29.35 | $1,000 | +0.0% |
| 1 month ago | $29.35 | $1,000 | +0.0% |
| 3 months ago | $29.35 | $1,000 | +0.0% |
| 6 months ago | $29.35 | $1,000 | +0.0% |
| All time ago | $7 | $4,193.57 | +319.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MCTA forecast.
Our base-case forecast reaches $59.00 around 2029.
Implied market cap at $59.00: $895.5M
Multi-year forecasts project a bullish trajectory beyond 2026, with the average price climbing from $41.64 in 2027 to $678.73 by 2050 and with substantial upside. For example, 2027’s avg is $41.64 (ROI 41.8%), rising through 2028 to an avg of $52.96 (ROI 80.4%), 2029 to $68.74 (ROI 134.2%), and 2030 to $84.39 (ROI 187.5%). The uptrend continues with 2031 avg $89.72 (ROI 205.6%), 2032 $103.16 (251.4%), 2033 $120.99 (312.1%), 2034 $139.41 (374.9%), and 2035 $174.13 (493.2%).
The forecast extends to 2040 with an avg of $272.54 (ROI 828.4%) and to 2050 with an avg of $678.73 (ROI 2212.1%). Throughout these years, the sentiment remains BULLISH. These are projections, not guarantees, and actual results may differ.
Tap a question to reveal the answer.
The 2030 forecast shows min $62.10, avg $84.39, max $123.75 with ROI 187.5 and sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward, with rising averages through 2030 and beyond (e.g., 2027 avg $41.64, 2030 avg $84.39, 2050 avg $678.73). These are estimates and not guarantees.
Yes, the 2030 max is $123.75, and the 2029 max is $98.33, so the upside could push beyond $100 by 2030 according to the forecast.
RSI14 is 80, SMA50 is $29.35, and the 30-day range is $26.41–$32.62. Support and resistance are both at $29.35, with annualized volatility at 30%.
Current price is $29.36, market cap is $504.26M, and the rank is 2854.
Charming Medical Limited Community Discussion
0Share your Charming Medical Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.